Nawaloka Hospitals PLC (COSE:NHL.N0000)
Sri Lanka
· Delayed Price · Currency is LKR 10.50
0.00 (0.00%)
At close: Dec 5, 2025
Nawaloka Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 11,778 | 11,013 | 10,379 | 9,305 | 15,302 | 11,828 | Upgrade
|
| Revenue Growth (YoY) | 7.61% | 6.10% | 11.54% | -39.19% | 29.38% | 30.90% | Upgrade
|
| Cost of Revenue | 5,383 | 5,134 | 4,763 | 4,670 | 7,461 | 6,285 | Upgrade
|
| Gross Profit | 6,394 | 5,878 | 5,617 | 4,635 | 7,841 | 5,542 | Upgrade
|
| Selling, General & Admin | 5,217 | 4,910 | 4,618 | 3,860 | 4,856 | 3,753 | Upgrade
|
| Other Operating Expenses | -148.26 | -143.57 | -37.47 | 258.91 | 232.59 | -37.37 | Upgrade
|
| Operating Expenses | 5,178 | 4,875 | 4,592 | 4,709 | 5,927 | 4,042 | Upgrade
|
| Operating Income | 1,216 | 1,003 | 1,025 | -73.46 | 1,914 | 1,501 | Upgrade
|
| Interest Expense | -1,030 | -927.89 | -1,491 | -1,951 | -1,035 | -1,162 | Upgrade
|
| Interest & Investment Income | 32.13 | 28.95 | 37.56 | 58.58 | 53.46 | 48.27 | Upgrade
|
| Earnings From Equity Investments | 223.04 | 223.04 | 148.53 | 159.89 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 4.3 | 4.3 | 33.73 | -102.56 | -215 | -24.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | 0 | - | -2.08 | -7.64 | -18.03 | Upgrade
|
| EBT Excluding Unusual Items | 445.63 | 331.79 | -247.01 | -1,911 | 709.67 | 344.61 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.41 | 0.41 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.14 | 1.14 | - | - | -253.66 | 2.57 | Upgrade
|
| Asset Writedown | 3.3 | 3.3 | - | - | - | - | Upgrade
|
| Pretax Income | 1,111 | 336.64 | -247.01 | -1,911 | 456.02 | 347.17 | Upgrade
|
| Income Tax Expense | 373.1 | 280.26 | 57.74 | 527.67 | 552.61 | -154.09 | Upgrade
|
| Net Income | 738.15 | 56.38 | -304.75 | -2,438 | -96.59 | 501.26 | Upgrade
|
| Net Income to Common | 738.15 | 56.38 | -304.75 | -2,438 | -96.59 | 501.26 | Upgrade
|
| Net Income Growth | 3234.05% | - | - | - | - | 3036.68% | Upgrade
|
| Shares Outstanding (Basic) | 1,420 | 1,410 | 1,410 | 1,410 | 1,410 | 1,410 | Upgrade
|
| Shares Outstanding (Diluted) | 1,420 | 1,410 | 1,410 | 1,410 | 1,410 | 1,410 | Upgrade
|
| EPS (Basic) | 0.52 | 0.04 | -0.22 | -1.73 | -0.07 | 0.36 | Upgrade
|
| EPS (Diluted) | 0.52 | 0.04 | -0.22 | -1.73 | -0.07 | 0.36 | Upgrade
|
| EPS Growth | 4201.44% | - | - | - | - | 3456.31% | Upgrade
|
| Free Cash Flow | -407.71 | 792.79 | 2,047 | 2,752 | 1,259 | -65.36 | Upgrade
|
| Free Cash Flow Per Share | -0.29 | 0.56 | 1.45 | 1.95 | 0.89 | -0.05 | Upgrade
|
| Gross Margin | 54.29% | 53.38% | 54.12% | 49.81% | 51.24% | 46.86% | Upgrade
|
| Operating Margin | 10.33% | 9.11% | 9.87% | -0.79% | 12.51% | 12.69% | Upgrade
|
| Profit Margin | 6.27% | 0.51% | -2.94% | -26.21% | -0.63% | 4.24% | Upgrade
|
| Free Cash Flow Margin | -3.46% | 7.20% | 19.73% | 29.58% | 8.23% | -0.55% | Upgrade
|
| EBITDA | 2,025 | 1,806 | 1,851 | 754.97 | 2,744 | 2,329 | Upgrade
|
| EBITDA Margin | 17.19% | 16.40% | 17.83% | 8.11% | 17.93% | 19.69% | Upgrade
|
| D&A For EBITDA | 808.37 | 802.41 | 825.97 | 828.43 | 830.28 | 828.33 | Upgrade
|
| EBIT | 1,216 | 1,003 | 1,025 | -73.46 | 1,914 | 1,501 | Upgrade
|
| EBIT Margin | 10.33% | 9.11% | 9.87% | -0.79% | 12.51% | 12.69% | Upgrade
|
| Effective Tax Rate | 33.58% | 83.25% | - | - | 121.18% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.